Amyotrophic lateral sclerosis<unk>  was approved in the United States for the treatment of ALS by the U.S. Food and Drug Administration (FDA) in 1995. A Cochrane Library review states a 9% gain in the probability of surviving one year.
Riluzole
Glatiramer acetate
Inotersen
Glybuzole
Nusinersen
Fingolimod
Tocilizumab
Glysobuzole